The GeneType team is excited to announce that the Colorectal Cancer Risk Assessment Test isnow available for purchasethrough a 3rd party telehealth provider!
Due to the pandemic, the rates of routine colorectal cancer screenings have gone down. In honor of Colorectal Cancer Awareness month, we are encouraging all of our subscribers to get back on track and receive their recommended screenings.
Here are a few keyrisk factorsfor colorectal cancer:
- Age
- Family history
- Genomics
- Ethnicity/Race
- Your health conditions
What makes GeneType for Colorectal Cancer so effective is that it considers your age, family history,andpersonal genetic makeup in one comprehensive risk assessment.
The test will tell you if you have an average or increased risk for colorectal cancer. Once you receive your results, you and your healthcare provider can use this information to develop a personalized screening and risk reduction plan.
Take charge of your health today and know your risk with GeneType for Colorectal Cancer!
- Forums
- ASX - By Stock
- News: GTG Genetic Technologies Signs Multi-Year US Distribution Agreement For COVID Risk Test
GTG
genetic technologies limited
Add to My Watchlist
0.00%
!
3.9¢

"s on in my mailbox :The GeneType team is excited to announce...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
3.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $52.08M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
GTG (ASX) Chart |
Day chart unavailable
The Watchlist
VMM
VIRIDIS MINING AND MINERALS LIMITED
Rafael Moreno, CEO
Rafael Moreno
CEO
SPONSORED BY The Market Online